- Home
- APO vs ZTS Comparison
APO vs ZTS Comparison
Compare APO & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APO
- ZTS
- Stock Information
- Founded
- APO 1990
- ZTS 1952
- Country
- APO United States
- ZTS United States
- Employees
- APO N/A
- ZTS N/A
- Industry
- APO Investment Managers
- ZTS Biotechnology: Pharmaceutical Preparations
- Sector
- APO Finance
- ZTS Health Care
- Exchange
- APO Nasdaq
- ZTS Nasdaq
- Market Cap
- APO 76.6B
- ZTS 75.1B
- IPO Year
- APO 2011
- ZTS 2013
- Fundamental
- Price
- APO $134.52
- ZTS $157.13
- Analyst Decision
- APO Strong Buy
- ZTS Buy
- Analyst Count
- APO 20
- ZTS 8
- Target Price
- APO $157.30
- ZTS $211.50
- AVG Volume (30 Days)
- APO 2.6M
- ZTS 2.8M
- Earning Date
- APO 07-31-2025
- ZTS 08-05-2025
- Dividend Yield
- APO 1.51%
- ZTS 1.27%
- EPS Growth
- APO N/A
- ZTS 7.32
- EPS
- APO 5.73
- ZTS 5.57
- Revenue
- APO $24,387,000,000.00
- ZTS $9,286,000,000.00
- Revenue This Year
- APO N/A
- ZTS $3.54
- Revenue Next Year
- APO $18.47
- ZTS $6.11
- P/E Ratio
- APO $23.57
- ZTS $28.22
- Revenue Growth
- APO N/A
- ZTS 6.32
- 52 Week Low
- APO $95.11
- ZTS $139.70
- 52 Week High
- APO $189.49
- ZTS $200.33
- Technical
- Relative Strength Index (RSI)
- APO 51.17
- ZTS 39.98
- Support Level
- APO $131.43
- ZTS $154.54
- Resistance Level
- APO $139.50
- ZTS $168.83
- Average True Range (ATR)
- APO 2.91
- ZTS 3.41
- MACD
- APO 0.07
- ZTS -1.67
- Stochastic Oscillator
- APO 58.94
- ZTS 12.41
About APO Apollo Global Management Inc. (New)
Apollo Global Management Inc is an alternative investment manager. It serves various sectors such as chemicals, manufacturing and industrial, natural resources, consumer and retail, consumer services, business services, financial services, leisure, and media and telecom and technology. The company operates in three business segments that are Asset Management, Retirement Services, and Principal Investing. It generates maximum revenue from the Retirement Services segment.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.